Diamond Hill Capital Management LLC Investment Advisor Takes Position in Molina Healthcare, Inc $MOH

Diamond Hill Capital Management LLC Investment Advisor purchased a new position in shares of Molina Healthcare, Inc (NYSE:MOH) in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 99,066 shares of the company’s stock, valued at approximately $22,656,000. Diamond Hill Capital Management LLC Investment Advisor owned 0.19% of Molina Healthcare at the end of the most recent quarter.

Other large investors also recently bought and sold shares of the company. Torren Management LLC purchased a new position in Molina Healthcare during the fourth quarter worth about $26,000. Physician Wealth Advisors Inc. raised its stake in shares of Molina Healthcare by 1,250.0% in the 1st quarter. Physician Wealth Advisors Inc. now owns 216 shares of the company’s stock valued at $29,000 after acquiring an additional 200 shares during the period. Quarry LP purchased a new stake in shares of Molina Healthcare in the 4th quarter valued at approximately $32,000. SJS Investment Consulting Inc. lifted its holdings in shares of Molina Healthcare by 504.9% in the 1st quarter. SJS Investment Consulting Inc. now owns 248 shares of the company’s stock worth $33,000 after acquiring an additional 207 shares during the last quarter. Finally, Elevation Wealth Partners LLC boosted its position in shares of Molina Healthcare by 118.2% during the 2nd quarter. Elevation Wealth Partners LLC now owns 144 shares of the company’s stock worth $33,000 after purchasing an additional 78 shares during the period. Institutional investors and hedge funds own 98.50% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts recently weighed in on MOH shares. Zacks Research upgraded shares of Molina Healthcare from a “hold” rating to a “strong-buy” rating in a report on Thursday, July 23rd. Barclays lowered their price target on Molina Healthcare from $184.00 to $180.00 and set an “underweight” rating for the company in a research report on Friday, July 24th. Morgan Stanley lifted their price objective on Molina Healthcare from $146.00 to $167.00 and gave the company an “equal weight” rating in a research note on Thursday, June 4th. Wells Fargo & Company cut their price objective on Molina Healthcare from $235.00 to $220.00 and set an “equal weight” rating on the stock in a report on Tuesday, July 28th. Finally, Robert W. Baird increased their target price on Molina Healthcare from $124.00 to $163.00 and gave the stock a “neutral” rating in a research note on Monday, May 11th. One analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, eleven have issued a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $202.44.

Molina Healthcare Stock Down 0.1%

Molina Healthcare stock opened at $212.24 on Monday. The firm has a market capitalization of $11.08 billion, a P/E ratio of -1,179.07, a P/E/G ratio of 30.44 and a beta of 0.75. The company has a current ratio of 1.68, a quick ratio of 1.68 and a debt-to-equity ratio of 0.95. Molina Healthcare, Inc has a twelve month low of $121.06 and a twelve month high of $244.89. The stock’s fifty day simple moving average is $210.98 and its 200-day simple moving average is $177.92.

Molina Healthcare (NYSE:MOH) last released its earnings results on Wednesday, July 22nd. The company reported $1.51 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.39 by $0.12. Molina Healthcare had a positive return on equity of 3.73% and a negative net margin of 0.02%.The firm had revenue of $10.87 billion during the quarter, compared to analyst estimates of $10.83 billion. During the same period last year, the business posted $5.48 earnings per share. Molina Healthcare’s revenue was down 4.8% compared to the same quarter last year. As a group, equities analysts expect that Molina Healthcare, Inc will post 5.29 earnings per share for the current fiscal year.

Molina Healthcare News Roundup

Here are the key news stories impacting Molina Healthcare this week:

• Positive Sentiment: Zacks Research raised multiple future EPS forecasts and reiterated a “Strong-Buy” rating. Estimates increased for Q4 2026 to $0.70 from $0.53, Q1 2027 to $2.53 from $1.60, Q2 2027 to $2.22 from $1.82, Q4 2027 to $2.87 from $2.00, FY2027 to $10.05 from $7.61, and FY2028 to $11.94 from $9.76. The revisions suggest analysts see stronger earnings power beyond the near term, although the current-year consensus remains $5.29 per share.
• Positive Sentiment: Recent quarterly results and raised guidance are supporting a recovery in sentiment. Molina reported second-quarter adjusted EPS of $1.51, above expectations, and increased its minimum 2026 adjusted earnings outlook to $5.25 from $5.00. Investors appear to be reassessing the stock after its post-earnings selloff, with Medicaid policy clarity and resilient profitability helping drive the rebound. Molina Healthcare Surged on Medicaid Clarity and Robust Results
• Positive Sentiment: Investor interest from Michael Burry provides an additional sentiment boost. Burry reportedly added to his Molina position at approximately $198, signaling confidence in the company’s valuation and longer-term healthcare prospects ahead of election-related Medicaid policy discussions. Michael Burry Adds to Molina Healthcare Position
• Neutral Sentiment: Not all estimate changes were favorable. Zacks reduced its Q3 2026 EPS forecast to $0.72 from $1.07 and cut Q2 2028 EPS to $2.30 from $2.60, underscoring continuing near-term earnings and cost pressures.
• Negative Sentiment: Insider transactions were weighted toward selling. Company insiders recorded three sales versus one purchase over the past six months, a potentially cautious signal, though these transactions do not necessarily reflect management’s outlook.

About Molina Healthcare

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.